Lucida Medical
Cambridge
About Lucida Medical
Software to support analysis of MRI for cancer diagnosis, screening and management. Pi(tm), the company's first product, supports diagnosis of prostate cancer using multiparametric or diffusion MRI and is a CE marked medical device. We are interested to speak with investors and hospital partners who share our vision to find cancer early.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $22.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2026)
- Website: lucidamedical.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Oncology, Software
Social Profiles
Canonical: https://fsome.com/organization/lucida-medical-49200 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.